Dedicated to the early detection of ovarian cancer through funding research, education, and awareness.
The Honorable Tina Brozman Fdtn Inc has made early detection of ovarian cancer the through line of its grantmaking, with awards repeatedly going to research teams building screening tools, biomarker-based approaches, and prevention strategies. Its active programs include the Tina’s Wish Rising Star Grant for early-career researchers and the Tina’s Wish Team Science Grant for collaborative projects, both centered on ovarian cancer detection and prevention. Recent grants show a consistent pattern of support for major cancer and university research centers: Johns Hopkins University received $423,000 in 2025 for early detection of ovarian cancer, while Dana Farber Cancer Institute received $233,333 in 2024 and $232,407 in 2025 for the same purpose. The foundation also backs institutions working on translational research in this area, including Memorial Sloan Kettering, University of Chicago, University of Kansas, and UT Southwestern. Across the recent list, the funding is aimed at research that can move from scientific development toward practical detection or prevention methods rather than broad cancer philanthropy.
In biomarker and diagnostics work, the foundation supported Massachusetts Institute of Technology with $130,000 in both 2024 and 2025 for early detection of ovarian cancer. For clinical validation and translational research, Brigham and Women’s Hospital received $100,000 in 2024 and again in 2025, also for early detection of ovarian cancer. The portfolio includes support for screening-focused research at UCLA, which received $100,000 in 2024 and $100,000 in 2025 for the same purpose. Collaborative science appears as well: UT Southwestern received $200,000 in 2024 and $200,000 in 2025 for early detection of ovarian cancer, fitting the foundation’s emphasis on team-based work.
Typical grants sit at $75,000 at the 25th percentile, $150,000 at the median, and $200,000 at the 75th percentile. The recent list shows repeat funding to the same institutions across multiple years, including Johns Hopkins University, Dana Farber Cancer Institute, Memorial Sloan Kettering, University of Kansas, University of Chicago, Columbia University, and University of Michigan. The foundation is a public charity, funds organizations rather than individuals, and operates with open grant tracks that accept unsolicited proposals in the United States. Its structure and published grant programs point to a formal research-grantmaking model rather than a one-off award pattern.
$2.3M
$6.9M
$4.2M
$3.9M
Most grants fall between $75K and $200K, with a median of $150K.
25th Percentile
$75K
Median
$150K
75th Percentile
$200K
About 13% of grants go to recipients in MA.
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
The grant list is entirely U.S.-based, with 40 grants to U.S. recipients. New York, NY appears among recipients through Memorial Sloan Kettering and Columbia University, while Texas is the top state by grant count overall. Other frequently appearing recipient cities include Baltimore, Boston, Chicago, Dallas, Lawrence, Philadelphia, Cambridge, Somerville, Los Angeles, and Ann Arbor. The foundation’s headquarters are in New York, NY, but its giving reaches major research centers across multiple states.
It funds research, education, and awareness focused on the early detection of ovarian cancer. The active programs emphasize early-career research and team-based projects, and the recent grant list is centered on research institutions working on screening, biomarker discovery, and prevention strategies.
The typical grant size is $75,000 at the 25th percentile, $150,000 at the median, and $200,000 at the 75th percentile. Recent awards also show larger research grants such as $423,000 to Johns Hopkins University and $233,333 to Dana Farber Cancer Institute.
Yes. The active Tina’s Wish grant programs state that they accept unsolicited applications in the United States, including the Rising Star Grant and the Team Science Grant.
The foundation gives nationally, but Texas is the top state by grant count among recipients. The recent recipient list also includes organizations in Maryland, Massachusetts, New York, Illinois, Kansas, Pennsylvania, California, and Michigan.
Yes. Several recipients appear in multiple years, including Johns Hopkins University in 2023, 2024, and 2025; Dana Farber Cancer Institute in 2024 and 2025; and Memorial Sloan Kettering, University of Chicago, University of Kansas, Columbia University, and University of Michigan across 2024 and 2025.
2025
Source: IRS Form 990-PF, fiscal year 2025.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| JOHN HOPKINS UNIVERSITY | BALTIMORE, MD | $423,000 | 2025 | EARLY DETECTION OF OVARIAN CANCER |
| DANA FARBER CANCER INSTITUTE | BOSTON, MA | $232,407 | 2025 | EARLY DETECTION OF OVARIAN CANCER |
| UNIVERSITY OF CHICAGO | CHICAGO, IL | $200,000 | 2025 | EARLY DETECTION OF OVARIAN CANCER |
| UT SOUTHWESTERN | DALLAS, TX | $200,000 | 2025 | EARLY DETECTION OF OVARIAN CANCER |
| UNIVERSITY OF KANSAS | LAWRENCE, KS | $200,000 | 2025 | EARLY DETECTION OF OVARIAN CANCER |
| MEMORIAL SLOAN KETTERING | NEW YORK, NY | $200,000 | 2025 | EARLY DETECTION OF OVARIAN CANCER |
| UNIVERSITY OF PENNSYLVANIA | PHILADELPHIA, PA | $166,667 | 2025 | EARLY DETECTION OF OVARIAN CANCER |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | CAMBRIDGE, MA | $130,000 | 2025 | EARLY DETECTION OF OVARIAN CANCER |
| BRIGHAM AND WOMEN'S HOSPITAL | SOMERVILLE, MA | $100,000 | 2025 | EARLY DETECTION OF OVARIAN CANCER |
| UCLA | LOS ANGELES, CA | $100,000 | 2025 | EARLY DETECTION OF OVARIAN CANCER |
| COLUMBIA UNIVERSITY | NEW YORK, NY | $100,000 | 2025 | EARLY DETECTION OF OVARIAN CANCER |
| UNIVERSITY OF MICHIGAN | ANN ARBOR, MI | $77,000 | 2025 | EARLY DETECTION OF OVARIAN CANCER |
| THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | SOUTH LEAGUE CITY, TX | $75,000 | 2025 | EARLY DETECTION OF OVARIAN CANCER |
| VIRGINIA COMMONWEALTH UNIVERSITY | RICHMOND, VA | $75,000 | 2025 | EARLY DETECTION OF OVARIAN CANCER |
| UNIV OF PITTSBURGH | PITTSBURGH, PA | $70,000 | 2025 | EARLY DETECTION OF OVARIAN CANCER |
| JOHNS HOPKINS UNIVERSITY | BALTIMORE, MD | $300,000 | 2024 | EARLY DETECTION OF OVARIAN CANCER |
| DANA FARBER CANCER INSTITUTE | BOSTON, MA | $233,333 | 2024 | EARLY DETECTION OF OVARIAN CANCER |
| MEMORIAL SLOAN KETTERING | NEW YORK, NY | $200,000 | 2024 | EARLY DETECTION OF OVARIAN CANCER |
| UNIVERSITY OF CHICAGO | CHICAGO, IL | $200,000 | 2024 | EARLY DETECTION OF OVARIAN CANCER |
| UNIVERSITY OF KANSAS | LAWRENCE, KS | $200,000 | 2024 | EARLY DETECTION OF OVARIAN CANCER |
| UT SOUTHWESTERN | DALLAS, TX | $200,000 | 2024 | EARLY DETECTION OF OVARIAN CANCER |
| MD ANDERSON | SOUTH LEAGUE CITY, TX | $198,000 | 2024 | EARLY DETECTION OF OVARIAN CANCER |
| UNIVERSITY OF PENNSYLVANIA | PHILADELPHIA, PA | $166,667 | 2024 | EARLY DETECTION OF OVARIAN CANCER |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | CAMBRIDGE, MA | $130,000 | 2024 | EARLY DETECTION OF OVARIAN CANCER |
| UCLA | LOS ANGELES, CA | $100,000 | 2024 | EARLY DETECTION OF OVARIAN CANCER |
| COLUMBIA UNIVERSITY | NEW YORK, NY | $100,000 | 2024 | EARLY DETECTION OF OVARIAN CANCER |
| BRIGHAM AND WOMEN'S HOSPITAL | SOMERVILLE, MA | $100,000 | 2024 | EARLY DETECTION OF OVARIAN CANCER |
| UNIVERSITY OF MICHIGAN | ANN ARBOR, MI | $77,000 | 2024 | EARLY DETECTION OF OVARIAN CANCER |
| VIRGINIA COMMONWEALTH UNIVERSITY | RICHMOND, VA | $75,000 | 2024 | EARLY DETECTION OF OVARIAN CANCER |
| UNIV OF PITTSBURGH | PITTSBURGH, PA | $70,000 | 2024 | EARLY DETECTION OF OVARIAN CANCER |
| JOHNS HOPKINS UNIVERSITY | BALTIMORE, MD | $300,000 | 2023 | EARLY DETECTION OF OVARIAN CANCER |
| UNIVERSITY OF KANSAS | LAWRENCE, KS | $150,000 | 2023 | EARLY DETECTION OF OVARIAN CANCER |
| DANA FARBER CANCER INSTITUTE | BOSTON, MA | $150,000 | 2023 | EARLY DETECTION OF OVARIAN CANCER |
| UNIVERSITY OF CHICAGO | CHICAGO, IL | $150,000 | 2023 | EARLY DETECTION OF OVARIAN CANCER |
| MEMORIAL SLOAN KETTERING | NEW YORK, NY | $150,000 | 2023 | EARLY DETECTION OF OVARIAN CANCER |
| BRIGHAM AND WOMEN'S HOSPITAL | SOMERVILLE, MA | $75,000 | 2023 | EARLY DETECTION OF OVARIAN CANCER |
| THE WISTAR INSTITUTE | PHILADELPHIA, PA | $75,000 | 2023 | EARLY DETECTION OF OVARIAN CANCER |
| REGENTS OF THE UNIV OF CALI | OAKLAND, CA | $75,000 | 2023 | EARLY DETECTION OF OVARIAN CANCER |
| UNIVERSITY OF PENNSYLVANIA | PHILADELPHIA, PA | $75,000 | 2023 | EARLY DETECTION OF OVARIAN CANCER |
| UNIV OF PITTSBURGH | PITTSBURGH, PA | $75,000 | 2023 | EARLY DETECTION OF OVARIAN CANCER |
UT SOUTHWESTERN
$200,000EARLY DETECTION OF OVARIAN CANCER
UNIVERSITY OF KANSAS
$200,000EARLY DETECTION OF OVARIAN CANCER
EARLY DETECTION OF OVARIAN CANCER
BRIGHAM AND WOMEN'S HOSPITAL
$100,000EARLY DETECTION OF OVARIAN CANCER
UCLA
$100,000EARLY DETECTION OF OVARIAN CANCER
UNIVERSITY OF MICHIGAN
$77,000EARLY DETECTION OF OVARIAN CANCER
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
$75,000EARLY DETECTION OF OVARIAN CANCER
VIRGINIA COMMONWEALTH UNIVERSITY
$75,000EARLY DETECTION OF OVARIAN CANCER
UNIVERSITY OF KANSAS
$200,000EARLY DETECTION OF OVARIAN CANCER
UT SOUTHWESTERN
$200,000EARLY DETECTION OF OVARIAN CANCER
MD ANDERSON
$198,000EARLY DETECTION OF OVARIAN CANCER
UCLA
$100,000EARLY DETECTION OF OVARIAN CANCER
BRIGHAM AND WOMEN'S HOSPITAL
$100,000EARLY DETECTION OF OVARIAN CANCER
UNIVERSITY OF MICHIGAN
$77,000EARLY DETECTION OF OVARIAN CANCER
VIRGINIA COMMONWEALTH UNIVERSITY
$75,000EARLY DETECTION OF OVARIAN CANCER
UNIVERSITY OF KANSAS
$150,000EARLY DETECTION OF OVARIAN CANCER
BRIGHAM AND WOMEN'S HOSPITAL
$75,000EARLY DETECTION OF OVARIAN CANCER
THE WISTAR INSTITUTE
$75,000EARLY DETECTION OF OVARIAN CANCER
REGENTS OF THE UNIV OF CALI
$75,000EARLY DETECTION OF OVARIAN CANCER